Skip to main content

May 2016

 

 

academics

 

Clinical research courses

Looking for Area Manager in Leading Pharma Company- Nextus

Leading Pharma Company

Post: Area Manager

Job as HEAD - Pharmacovigilance at Global Allied Pharmaceuticals

Global Allied Pharmaceuticals (GAP): Imagine a company which the allure of innovation meets excellence, skill fuses with services, and perfection blends with production.
GAP is a robust, nimble, and state-of-the-art provider of bio-pharmaceutical Contract Development Manufacturing, Research, Business Processing Organization, and Strategic Consulting group We are a bricks and Mortar company.
We employ 1682 Full Time Employees in 49 countries with offices in N. American, Latin America, Common Wealth of Russia as well as India. In short, we empower our clients both locally and globally.

Post: HEAD - Pharmacovigilance

Career as Executive - Training & Development (Hospital Pharmacies) at Apollo Hospitals

Apollo Hospitals is the forerunner of integrated healthcare in Asia, as well as globally. The group's futuristic vision has ensured that it has been in a position of strength at every touch point of the healthcare delivery chain. Its presence encompasses across 56 hospitals, more than 2300 pharmacies, over 100 primary care & diagnostic clinics, 115 telemedicine units across 9 countries, health insurance services, global projects consultancy, 15 academic institutions and a Research Foundation with a focus on global clinical trials, epidemiological studies, stem-cell and genetic research.
Over the past three decades Apollo Hospitals' transformative journey has forged a legacy of excellence in Indian healthcare. The Group has continuously set the agenda and led by example in the blossoming private healthcare space. One of Apollo's significant contributions has been the adoption of clinical excellence as an industry standard. Apollo pioneered the concept - the group was the first to invest in the pre-requisites that led to international quality accreditation like the JCI and also developed centers of excellence in Cardiac Sciences, Orthopedics, Neurosciences, Emergency Care, Cancer and Organ Transplantation. Along with excellence the Apollo philosophy rests on the pillars of technological superiority, a warm patent- centric approach, a clear and distinct cost advantage and a edge in forward-looking research. Apollo's spectacular success rests on sustained commitment and investments in each of these pillars.

Post: Executive - Training & Development (Hospital Pharmacies) - 2 posts

Job for Medical Representatives at Tweet India Pharmaceuticals

Tweet India Pharmaceuticals Pvt. Ltd. is being headed by Mr. A. K. Arora, who is backed up by his more than 35 years practical and successful experiences of Pharmaceutical Industry and has given his precious and valuable guidance in formulating latest strategies which is followed by many Pharmaceutical Companies, and has been the milestone for the Pharmaceutical Industries.

Post: Medical Representative

Job as Manager Pharmacovigilance at Global Allied Pharmaceuticals

Imagine a company which the allure of innovation meets excellence, skill fuses with services, and perfection blends with production. GAP is a robust, nimble, and state-of-the-art provider of bio-pharmaceutical Contract Development Manufacturing, Research, Business Processing Organization, and Strategic Consulting group We are a bricks and Mortar company. We employ 1682 Full Time Employees in 49 countries with offices in N. American, Latin America, Common Wealth of Russia as well as India. In short, we empower our clients both locally and globally

Post: Manager Pharmacovigilance

Cardiome Pharma Corp. announced that it has signed an exclusive license agreement with an Allergan to  commercialize XYDALBA™ (Dalbavancin) in France, the U.K., Germany, Belgium, Nordic nations, certain other European nations (not already partnered), various Middle Eastern nations and Canada.

(adsbygoogle = window.adsbygoogle || []).push({});

Concert Pharmaceuticals Inc. announced launch of CTP-543 for the treatment of alopecia areata. Alopecia areata is an autoimmune disease characterized by patchy or widespread hair loss, for which there is significant unmet medical need and currently no FDA-approved treatment. CTP-543 is a deuterium-modified analog of ruxolitinib, which selectively inhibits Janus kinases 1 and 2, known as JAK1 and JAK2.

Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Fenofibrate Tablets, 48 mg and 145 mg. Fenofibrate Tablet is used to treat high level of cholesterol and triglyceride in the blood. Product is expected to be launched in Q1 FY16-17.